These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6127329)

  • 21. Beta-adrenergic blockade after myocardial infarction: clinical and public health implications of the reported beta-blocker clinical trials.
    Friedewald WT
    Circulation; 1983 Jun; 67(6 Pt 2):I110-1. PubMed ID: 6133641
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?
    Baber NS; Lewis JA
    Circulation; 1983 Jun; 67(6 Pt 2):I71-7. PubMed ID: 6133647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
    Mösslacher H
    Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of long-term beta-blocker trials in survivors of myocardial infarction.
    May GS
    Circulation; 1983 Jun; 67(6 Pt 2):I46-9. PubMed ID: 6133644
    [No Abstract]   [Full Text] [Related]  

  • 25. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial infarction in the 1990s. The importance of early thrombolytic therapy.
    Fowles RE
    Postgrad Med; 1995 May; 97(5):135-8, 141-2, 145-6. PubMed ID: 7753739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin, aspirin and beta-blockers in the acute myocardial infarction period.
    Cruickshank JM
    Therapie; 1992; 47(2):121. PubMed ID: 1357769
    [No Abstract]   [Full Text] [Related]  

  • 28. [Secondary prevention following myocardial infarct. Which drug treatment is safe today?].
    Bungeroth KA
    Fortschr Med; 1987 Oct; 105(31):607-11. PubMed ID: 2891595
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-blockade after myocardial infarction.
    Drug Ther Bull; 1977 Apr; 15(9):33-4. PubMed ID: 17532
    [No Abstract]   [Full Text] [Related]  

  • 30. Reducing post-myocardial infarction mortality in the elderly: the power and promise of secondary prevention.
    Boden WE; Maron DJ
    J Am Coll Cardiol; 2008 Apr; 51(13):1255-7. PubMed ID: 18371554
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adrenergic beta receptor blockaders as a secondary prevention after acute myocardial infarction].
    Jensen G; Sigurd B
    Ugeskr Laeger; 1981 Nov; 143(48):3241-5. PubMed ID: 6120594
    [No Abstract]   [Full Text] [Related]  

  • 32. The anturane reinfarction trial.
    Rothlin M
    N Engl J Med; 1980 Jul; 303(1):48. PubMed ID: 6103510
    [No Abstract]   [Full Text] [Related]  

  • 33. [Relationship between mortality due to acute myocardial infarction and adherence to clinical guidelines].
    Coma-Canella I
    Rev Esp Cardiol; 2006 Mar; 59(3):189-92. PubMed ID: 16712740
    [No Abstract]   [Full Text] [Related]  

  • 34. [Why is it sometimes necessary to include a large number of patients in clinical trials?].
    Hill C
    Bull Cancer; 1989; 76(6):569-71. PubMed ID: 2570613
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of beta-blocker therapy on recurrent nonfatal myocardial infarction.
    Furberg CD; Bell RL
    Circulation; 1983 Jun; 67(6 Pt 2):I83-5. PubMed ID: 6133649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of sudden cardiac death with beta blockers.
    Hjalmarson A
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V11-5. PubMed ID: 10526698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction--but at what cost to Medicare?
    Moran A; Goldman L
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):606-7. PubMed ID: 18695697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Secondary prevention following myocardial infarction].
    Kan G; Jaarsma W; Visser CA; Manger Cats V; Lie KI
    Ned Tijdschr Geneeskd; 1983 Feb; 127(6):257-61. PubMed ID: 6131385
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of beta-blockers in the treatment of patients after infarction.
    Pratt CM; Young JB; Roberts R
    Cardiol Clin; 1984 Feb; 2(1):13-20. PubMed ID: 6152718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secondary prevention after myocardial infarction; role of beta blockaders].
    Cohen-Solal A; Seknadji P; Czitrom D; Boudvillain O
    Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():43-6. PubMed ID: 8949318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.